An in-depth look to BIOSERGEN AB operating, investing, and financing activities

BIOSGN free cash flow for Q3 24 is -9.28 M SEK. For 2023, BIOSGN free cash flow was -32.76 M SEK and operating cash flow was -32.76 M SEK.